Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-06-12
1988-11-22
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514269, 544295, 544319, A61K 31495, A61K 31505, C07D40304, C07D40104
Patent
active
047866381
ABSTRACT:
Disclosed herein are 2,4-disubstituted-5-cyano-1,6-dihydro-6-oxo-1-pyrimidineacetic acids and pharmaceutically acceptable salts thereof and methods of their preparation. The compounds are new aldose reductase inhibitors useful for the treatment or prevention of diabetic complications.
REFERENCES:
patent: 4505910 (1985-03-01), Bagli
patent: 4568693 (1986-02-01), Sestanj
patent: 4617393 (1986-10-01), Bagli
Kinoshita et al., Biochem. Biophys. Acta 158(1968) pp. 472-475.
Bobranski et al., CA 96-142888b.
Mitsui Toastsu Chemicals, Inc. CA97-110029b.
Vainilavicuiis et al. CA 105-191119q.
Alessi Thomas R.
Bagli Jehan F.
Ellingboe John W.
American Home Products Corporation
Daus Donald G.
Patton Walter
Shen Cecilia
LandOfFree
2,4-disubstituted-5-cyano-1,6-dihydro-6-oxo-1-pyrimidineacetic a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4-disubstituted-5-cyano-1,6-dihydro-6-oxo-1-pyrimidineacetic a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-disubstituted-5-cyano-1,6-dihydro-6-oxo-1-pyrimidineacetic a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-435524